Mirati Therapeutics, Inc.

Avoro Capital Advisors LLC

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/14/2024

Shares

4,886,840

Value ($000)

287,102

Weight

4.0%

2019 Q4 - 2023 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/14/2024	287,102	4.0%	4,886,840	12/31/2023
2023 Q3	11/14/2023	290,400	4.5%	6,666,666	9/30/2023
2023 Q2	8/14/2023	200,722	2.7%	5,555,555	6/30/2023
2023 Q1	5/15/2023	206,556	3.1%	5,555,555	3/31/2023
2022 Q4	2/14/2023	251,722	3.8%	5,555,555	12/31/2022
2022 Q3	11/14/2022	387,651	7.2%	5,550,555	9/30/2022
2022 Q2	8/15/2022	372,609	7.4%	5,550,555	6/30/2022
2022 Q1	5/16/2022	437,822	8.0%	5,325,000	3/31/2022
2021 Q4	2/14/2022	744,452	13%	5,075,000	12/31/2021
2021 Q3	11/15/2021	884,550	14%	5,000,000	9/30/2021
2021 Q2	8/16/2021	807,650	14%	5,000,000	6/30/2021
2021 Q1	5/17/2021	800,828	14%	4,675,000	3/31/2021
2020 Q4	2/16/2021	996,067	17%	4,535,000	12/31/2020
2020 Q3	11/16/2020	721,155	10%	4,343,000	9/30/2020
2020 Q2	8/14/2020	489,420	9.7%	4,286,765	6/30/2020
2020 Q1	5/15/2020	316,143	11%	4,112,700	3/31/2020
2019 Q4	2/14/2020	496,137	15%	3,850,200	12/31/2019